MEDIFAST INC (MED) Stock Analyst Earnings Estimates
NYSE:MED - New York Stock Exchange, Inc. - US58470H1014 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.599B 4.75% | 1.072B -32.94% | 602.463M -43.80% | 394M -34.60% | 379.56M -3.66% | |
| EBITDA YoY % growth | 195.8M -12.20% | 139.509M -28.75% | 32.176M -76.94% | -5.656M -117.58% | -9.292M -64.29% | |
| EBIT YoY % growth | 184.8M -14.52% | 126.402M -31.60% | 19.469M -84.60% | -17.372M -189.23% | -22.523M -29.65% | |
| Operating Margin | 11.56% | 11.79% | 3.23% | -4.41% | -5.93% | |
| EPS YoY % growth | 13.55 -2.45% | 9.11 -32.77% | 2.03 -77.72% | -1.01 -149.75% | -1.32 -31.00% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.22 -124.15% | -0.30 -186.57% | -0.37 -473.70% | -0.32 -158.56% | -0.15 31.82% | -0.02 95.00% | 0.06 116.22% |
| Revenue Q2Q % growth | 97.061M -42.42% | 94.738M -32.41% | 85.345M -28.28% | 95.142M -17.79% | 114.64M 18.11% | 114.99M 21.38% | 118.62M 38.99% |
| EBITDA Q2Q % growth | -100.00% | -3.03M -122.26% | -2.222M -116.14% | -3.131M -320.80% | 2.02M | 2.222M 173.33% | 5.202M 334.11% |
| EBIT Q2Q % growth | -4.242M -148.13% | -5.555M -235.82% | -6.363M -698.03% | -5.353M -187.49% | -3.131M 26.19% | -1.111M 80.00% | 50.5K 100.79% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.13 -118.94% | -0.27 | 0.15 | 54.16% |
| Q4 2024 Q2Q % growth | 0.10 -81.82% | -0.16 | 0.26 | 161.88% |
| Q3 2024 Q2Q % growth | 0.35 -83.49% | -0.28 | 0.63 | 225.10% |
| Q2 2024 Q2Q % growth | 0.92 -66.79% | 0.39 | 0.53 | 133.56% |
| Q1 2024 Q2Q % growth | 0.66 -82.02% | 0.79 | -0.13 | -16.22% |
| Q4 2023 Q2Q % growth | 0.55 -83.18% | 0.97 | -0.42 | -43.28% |
| Q3 2023 Q2Q % growth | 2.12 -35.17% | 1.08 | 1.04 | 97.09% |
| Q2 2023 Q2Q % growth | 2.77 -19.01% | 1.45 | 1.32 | 90.46% |
| Q1 2023 Q2Q % growth | 3.67 2.23% | 2.42 | 1.25 | 51.53% |
| Q4 2022 Q2Q % growth | 3.27 12.37% | 2.24 | 1.03 | 45.84% |
| Q3 2022 Q2Q % growth | 3.27 -8.15% | 1.93 | 1.34 | 69.51% |
| Q2 2022 Q2Q % growth | 3.42 -13.64% | 3.27 | 0.15 | 4.69% |
| Q1 2022 Q2Q % growth | 3.59 3.76% | 3.61 | -0.02 | -0.44% |
| Q4 2021 Q2Q % growth | 2.91 23.31% | 2.68 | 0.23 | 8.59% |
| Q3 2021 Q2Q % growth | 3.56 22.34% | 3.11 | 0.45 | 14.44% |
| Q2 2021 Q2Q % growth | 3.96 102.04% | 3.35 | 0.61 | 18.21% |
| Q1 2021 Q2Q % growth | 3.46 79.27% | 2.75 | 0.71 | 25.60% |
| Q4 2020 Q2Q % growth | 2.36 42.17% | 2.40 | -0.04 | -1.74% |
| Q3 2020 Q2Q % growth | 2.91 120.45% | 2.48 | 0.43 | 17.29% |
| Q2 2020 Q2Q % growth | 1.96 12.00% | 1.85 | 0.11 | 5.90% |
| Q1 2020 Q2Q % growth | 1.93 13.53% | 1.34 | 0.59 | 43.97% |
| Q4 2019 Q2Q % growth | 1.66 | 1.09 | 0.57 | 52.93% |
| Q3 2019 Q2Q % growth | 1.32 | 1.35 | -0.03 | -2.21% |
| Q2 2019 Q2Q % growth | 1.75 | 1.74 | 0.01 | 0.59% |
| Q1 2019 Q2Q % growth | 1.70 | 1.55 | 0.15 | 9.53% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 115.728M -33.77% | 111.2M | 4.528M | 4.07% |
| Q4 2024 Q2Q % growth | 119.003M -37.70% | 115.39M | 3.613M | 3.13% |
| Q3 2024 Q2Q % growth | 140.163M -40.58% | 135.49M | 4.673M | 3.45% |
| Q2 2024 Q2Q % growth | 168.558M -43.09% | 175.79M | -7.232M | -4.11% |
| Q1 2024 Q2Q % growth | 174.739M -49.93% | 170.59M | 4.149M | 2.43% |
| Q4 2023 Q2Q % growth | 191.015M -43.35% | 185.99M | 5.025M | 2.70% |
| Q3 2023 Q2Q % growth | 235.869M -39.58% | 234.42M | 1.449M | 0.62% |
| Q2 2023 Q2Q % growth | 296.188M -34.66% | 272.95M | 23.238M | 8.51% |
| Q1 2023 Q2Q % growth | 348.983M -16.43% | 322.71M | 26.273M | 8.14% |
| Q4 2022 Q2Q % growth | 337.2M -10.75% | 333.4M | 3.8M | 1.14% |
| Q3 2022 Q2Q % growth | 390.4M -5.56% | 352.79M | 37.61M | 10.66% |
| Q2 2022 Q2Q % growth | 453.3M 14.99% | 452.33M | 970K | 0.21% |
| Q1 2022 Q2Q % growth | 417.6M 22.57% | 407.29M | 10.31M | 2.53% |
| Q4 2021 Q2Q % growth | 377.8M 42.62% | 379.55M | -1.75M | -0.46% |
| Q3 2021 Q2Q % growth | 413.4M 52.27% | 407.79M | 5.61M | 1.38% |
| Q2 2021 Q2Q % growth | 394.2M 79.18% | 363.11M | 31.09M | 8.56% |
| Q1 2021 Q2Q % growth | 340.7M 90.87% | 281.68M | 59.02M | 20.95% |
| Q4 2020 Q2Q % growth | 264.9M 55.28% | 246.94M | 17.96M | 7.27% |
| Q3 2020 Q2Q % growth | 271.5M 42.82% | 243.02M | 28.48M | 11.72% |
| Q2 2020 Q2Q % growth | 220M 17.58% | 193.68M | 26.32M | 13.59% |
| Q1 2020 Q2Q % growth | 178.5M 7.59% | 167.37M | 11.13M | 6.65% |
| Q4 2019 Q2Q % growth | 170.6M | 163.3M | 7.3M | 4.47% |
| Q3 2019 Q2Q % growth | 190.1M | 197.12M | -7.02M | -3.56% |
| Q2 2019 Q2Q % growth | 187.1M | 184.09M | 3.01M | 1.64% |
| Q1 2019 Q2Q % growth | 165.9M | 155.01M | 10.89M | 7.03% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -175% | 0% | 4.76% |
| Revenue | 0% | -13.58% | 0% | -3.94% |